MediPharm Labs Financial Results Announcement
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) is excited to announce that it will release its first quarter financial results. This report will cover the period ending March 31, 2025, and is scheduled for release before the markets open on an upcoming Wednesday.
Details of the Conference Call
The executive team at MediPharm Labs will host a conference call and webcast to discuss these important financial results. The event is set for 10:00 a.m. Eastern time on the same Wednesday as the results release.
How to Join the Conference Call:
For those in North America, the toll-free number to call is (888) 330-2454. International participants can connect by dialing +1 (240) 789-2714. Make sure to enter Conference ID 4921762 when prompted. It's recommended that participants join the call approximately 15 minutes early to ensure a smooth experience.
Webcast Access
For individuals unable to join the live call, a replay will be available soon after the conclusion of the event. The webcast can be accessed by visiting the dedicated link provided by the company.
About MediPharm Labs
Founded in 2015, MediPharm Labs is recognized for its dedication to developing and manufacturing pharmaceutical-grade cannabis products. This commitment extends through precision-based formulations and purified cannabis concentrates that meet rigorous quality standards.
The company maintains state-of-the-art facilities that meet stringent regulations and practices. MediPharm Labs has successfully built a reputation for utilizing advanced extraction methodologies, ensuring that all products are pure, reliable, and accurately dosed for various needs.
Achievements and Expansions
In 2021, MediPharm Labs proudly received a Pharmaceutical Drug Establishment License from health authorities. This certification positioned them as the sole company in North America with a license for large-scale cannabis extraction using Good Manufacturing Practices, and they are now advancing towards registration with the US FDA.
Additionally, in 2023, MediPharm Labs expanded its reach by acquiring VIVO Cannabis Inc. This strategic move has significantly enhanced their footprint in the medical cannabis sector, making products more accessible across Canada, Australia, and Germany.
Community & Compliance
The company is fully committed to operating in compliance with all regulatory requirements within the jurisdictions they serve. MediPharm Labs prioritizes safety, quality, and innovation, ensuring that all products cater effectively to medical patients.
Connect with Us
For more information about MediPharm Labs, feel free to visit their official website.
Frequently Asked Questions
When will MediPharm Labs report its financial results?
MediPharm Labs is set to report its financial results before the markets open on a specified Wednesday.
How can I participate in the conference call?
Participants can join via phone or the webcast, and details are provided for toll-free and international calling.
What topics will be discussed during the conference call?
The call will primarily cover the company's financial results and future outlook.
What products does MediPharm Labs specialize in?
MediPharm Labs focuses on developing pharmaceutical-quality cannabis products and concentrates.
Where can I find more information about MediPharm Labs?
More information is available on their official website.
